UNSPSC 51281518: Bedaquiline

Definition: This classification is for a diarylquinolone used in the treatment of multi-drug resistant tuberculosis. BEDAQUILINE has a US FDA Unique Ingredient Identifier of 78846I289Y.

UNSPSC 51281518 Bedaquiline is a Commodity code that does not show relevant recent state and local procurement activity. The available opportunities tagged with this code include a county purchasing department relocation notice (Williamson County, Texas), two industry networking and trade show events (Marion County and Central Florida NIGP reverse trade shows), and multiple vendor education forums, none of which involve solicitation for bedaquiline or pharmaceutical products aligned with the code's scope. One opportunity labeled under a different pharmaceutical code—a Seminole County, Florida IFB for naloxone and safe drug deactivation systems (IFB60459723LAS, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building)—involves opioid-response pharmaceuticals but is not tagged to bedaquiline and closed nearly three years ago. A second pharmaceutical-related opportunity, the City of Tucson Fire Department's RFP 260217 for BLS/ALS pharmaceuticals and supplies (posted June 24, 2026, with federal funding through ARPA, HUD, and FTA), covers emergency medical services products, inventory management software, and vending systems rather than tuberculosis-specific therapeutics.

The code shows no identifiable pattern of recent state or local government procurement for bedaquiline, a second-line tuberculosis treatment. The notices present do not represent active buying demand under this commodity code. If your firm pursues this code, focus prospecting on state health departments, county public health authorities, and correctional systems in states with reported TB caseload or drug-resistant TB programs, rather than relying on the posted opportunities. The absence of visible solicitation activity under this code warrants direct outreach to potential users before investing in pre-bid preparation.